(L to R) Shaw Vision founder/chief scientist Peter Shaw, OD; EGMA president/CEO Poya Eghterafi; Shaw Vision vice president of sales Bill Stiles; EGMA director of manufacturing Ric Lee; and EGMA senior vice president Alan Yuster.
DALLAS—EGMA LLC has finalized an agreement to manufacture ophthalmic lenses under license from Shaw Vision Inc., a Toronto, Canada-based company that is the largest supplier of iseikonic and isophoric prescription eyeglass lens technology.

Shaw Vision’s founder and chief scientist, Peter Shaw, OD, an adjunct research professor at the University of Waterloo, Canada, received patents for the technology in 2013. Shaw Vision technology is available to the public from over 3,000 optometrists in over 20 countries.

EGMA, based here, is a full service digital lens manufacturer. It is the exclusive distributor in the U.S. and manufactures under license the Rodenstock series of advanced lens technology.